Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00903994 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee
A Phase 2 study, sponsored by APR Applied Pharma Research s.a..
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT00903994: Completed Phase 2 study, sponsored by APR Applied Pharma Research s.a..
NCT00903994 is a Phase 2 study that has completed, run by APR Applied Pharma Research s.a.. The registered enrollment target is 17 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00903994, a Phase 2 study, has completed, sponsored by APR Applied Pharma Research s.a..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
Open-label study to be conducted at 2 US investigational sites in subjects who have acute tendonitis or bursitis of the shoulder, elbow, or knee. Eligible subjects receive treatment with the KTP, applied once daily at the same application site for 3 consecutive days.
Interventions
- DRUG Ketoprofen Topical Patch 20%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
What the finished NCT00903994 record still lists
NCT00903994 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Ketoprofen Topical Patch 20% is the first listed.
NCT00903994 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00903994 about?
NCT00903994 is a clinical study titled "A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee". Open-label study to be conducted at 2 US investigational sites in subjects who have acute tendonitis or bursitis of the shoulder, elbow, or knee. Eligible subjects receive treatment with the KTP, applied once daily at the same application site for 3 consecutive days.
What is the current status of trial NCT00903994?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2007-06. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00903994?
The interventions under investigation include: Ketoprofen Topical Patch 20% (DRUG).
Who is sponsoring clinical trial NCT00903994?
This trial is sponsored by APR Applied Pharma Research s.a., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00903994's enrollment target sits among peer trials
17 1903rd of 2000 higher than 93 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia